Clarence Ojo, MD
Vascular Surgery · St. Cloud, MNNPI 1053650630
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Shockwave Medical, Inc accounts for 72.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $9,916 and has fallen 98.1% since, to $186 in 2025.
Across 31 payments — averaging $439.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$10K
- Medtronic$2K
- W. L. Gore & Associates, Inc.$1K
- Cardiovascular Systems Inc.$137
- Bard Peripheral Vascular, Inc.$132
- Silk Road Medical, Inc.$128
What the payments were for
- Speaking & faculty fees$6,60048%
- Travel & lodging$5,79643%
- Food & beverage$1,2179%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 8 | $9,916 |
| Medtronic | 8 | $2,121 |
| W. L. Gore & Associates, Inc. | 12 | $1,179 |
| Cardiovascular Systems Inc. | 1 | $137 |
| Bard Peripheral Vascular, Inc. | 1 | $132 |
| Silk Road Medical, Inc. | 1 | $128 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$9,778
- HawkOne$1,772
- GORE TAG Thoracic Endoprosthesis$993
- Diamondback Peripheral$137
- COVERA$132
- ENROUTE Transcarotid Neuroprotection System$128
- ENROUTE Transcarotid Stent System$128
- ENHANCE Transcarotid Peripheral Access Kit$128
- ENROUTE 0.014 Guidewire$128
- ENDURANT IIS$112
How this compares
$13,613 in reported general payments places this provider in the 80th percentile of 84 vascular surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 50 | $641 |
| Atorvastatin Calcium | 11 | $221 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in St. Cloud
- Yauhen TarbunouSt. Cloud$26K
- Todd RasmussenRochester$561K
- Matthew MelinRochester$196K
- Jesse ManungaMinneapolis$95K
- Joseph KaramMinneapolis$88K
- Derrick GreenMinneapolis$37K
- Fahad ShujaRochester$34K
- Christopher LevilleSaint Cloud$30K
- Mohammad KhasawnehRochester$30K
- William McMillanRobbinsdale$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.